Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07690917 · ClinicalTrials.gov registry record
A Study of a New PET Scanner in People With Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 90
- Enrollment target
NCT07690917: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07690917 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07690917 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
Study Summary
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
Primary Outcome
Detection of any new/additional lesions on the delayed scan will be recorded using standard clinical interpretation.
Interventions
- DIAGNOSTIC_TEST PET/CT
- DIAGNOSTIC_TEST Biograph Vision Quadra scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2029-06 |
What NCT07690917 shows while recruiting
NCT07690917 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which PET/CT is the first listed.
NCT07690917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07690917 about?
NCT07690917 is a clinical study titled "A Study of a New PET Scanner in People With Cancer". The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
What is the current status of trial NCT07690917?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2026-06-30. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07690917?
The interventions under investigation include: PET/CT (DIAGNOSTIC_TEST), Biograph Vision Quadra scanner (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07690917?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI